Effect of thimerosal on Ca(2+) movement and viability in human oral cancer cells. (Record no. 19067924)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02071 a2200613 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250515182505.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200911s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1477-0903 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1177/0960327109106548 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Kuo, L N |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20091130 |
| 245 00 - TITLE STATEMENT | |
| Title | Effect of thimerosal on Ca(2+) movement and viability in human oral cancer cells. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Human & experimental toxicology |
| Date of publication, distribution, etc. | May 2009 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 301-8 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Apoptosis |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Calcium |
| General subdivision | metabolism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Calcium Channel Blockers |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Calcium Channels, L-Type |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cell Line, Tumor |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cell Survival |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Chelating Agents |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dose-Response Relationship, Drug |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Egtazic Acid |
| General subdivision | analogs & derivatives |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Endoplasmic Reticulum |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Enzyme Inhibitors |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Estrenes |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mouth Neoplasms |
| General subdivision | pathology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Phosphodiesterase Inhibitors |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Protein Kinase C |
| General subdivision | antagonists & inhibitors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pyrrolidinones |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Thapsigargin |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Thimerosal |
| General subdivision | toxicity |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Type C Phospholipases |
| General subdivision | antagonists & inhibitors |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Huang, C J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fang, Y C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Huang, C C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wang, J L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lin, K L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chu, S T |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chang, H T |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chien, J M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Su, H H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chi, C C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chen, W C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tsai, J Y |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Liao, W C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tseng, L L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jan, C R |
| 773 0# - HOST ITEM ENTRY | |
| Title | Human & experimental toxicology |
| Related parts | vol. 28 |
| -- | no. 5 |
| -- | p. 301-8 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1177/0960327109106548">https://doi.org/10.1177/0960327109106548</a> |
| Public note | Available from publisher's website |
No items available.